Breaking News, Collaborations & Alliances

Evonik Partners with ST Pharm to Expand its RNA & Nucleic Acid Therapeutic Services

Aims to increase speed to market for drug developers working on nucleic acid therapeutics.

Author Image

By: Charlie Sternberg

Associate Editor

Evonik has partnered with ST Pharm, a CDMO based in South Korea that manufactures active ingredients for gene therapy, to expand its RNA and nucleic acid therapeutic services. Through the partnership, Evonik will be able to provide customized nucleic acids from ST Pharm alongside its portfolio of lipid and lipid nanoparticle (LNP) drug product development services. This streamlined approach aims to reduce complexity and increase speed-to-market for nucleic acid therapeutics. “Speed is critica...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters